In February’s issue ChemistryToday Brian Mullan Yposkesi’s Head of Development & Innovation has published an article on how C> are a fast growing and promising class of medicines, that offer the possibility of curing conditions with a genetic basis, that have few or no other options for patients.
Click here to read Brian’s article:
https://www.teknoscienze.com/wp-content/uploads/2022/02/Mullan_CO1_2022.pdf
